Drug and pharmaceutical recalls
17658 federal recalls on file. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIESTRADIOL, 6 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3006-32.
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugUnichem Pharmaceuticals USA Inc.Class IIIStop using Unichem Doxazosin 4 mg tablets
Tablets/Capsules Imprinted with Wrong ID
- 2026-02-18FDA-DrugPro Numb Tattoo Numbing Spray LLCClass IIStop using Pro Numb Tattoo Numbing Spray
cGMP deviations
- 2026-02-18FDA-DrugPro Numb Tattoo Numbing Spray LLCClass IIStop using Pro Numb Tattoo Numbing Spray
cGMP deviations
- 2026-02-11FDA-DrugSUN PHARMACEUTICAL INDUSTRIES INCClass IIStop using Sun Pharmaceutical Diclofenac Sodium Gel
Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
- 2026-02-11FDA-DrugHANDELNINE GLOBAL LLCClass IStop using Rheumacare capsules
CGMP Deviations: product found to contain lead.
- 2026-02-11FDA-DrugGranules Pharmaceuticals Inc.Class IIStop using Granules trazodone 50 mg
Presence of Foreign Tablets/Capsules
- 2026-02-11FDA-DrugGreen Lumber Holdings, LLCClass IStop using Green Lumber Natural Fuel For Men
Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil
- 2026-02-11FDA-DrugUnichem Pharmaceuticals USA Inc.Class IIStop using Unichem bisoprolol/hydrochlorothiazide tablets
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
- 2026-02-04FDA-DrugNOVADOZ PHARMACEUTICALS LLCClass IIIStop using recalled Novadoz glycopyrrolate solution
Failed Impurities/Degradation Specifications
- 2026-02-04FDA-DrugGreenstone LlcClass IIStop using Greenstone methylprednisolone Dosepak
Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
- 2026-02-04FDA-DrugSato Pharmaceutical Co., LtdClass IIStop using Sato INON ACE antacid tablets
Failed Disintegration Specifications: above the time expected.
- 2026-02-04FDA-DrugHaleon US Holdings LLCClass IIICheck your Parodontax mouthwash lot number
Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles.
- 2026-02-04FDA-DrugBaxter Healthcare CorporationClass IIStop using Baxter Sterile Water for Irrigation
Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution
- 2026-01-28FDA-DrugZydus Pharmaceuticals (USA) IncClass IIStop using Zydus Icosapent Ethyl capsules
Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
- 2026-01-28FDA-DrugSpecialty Process Labs LLCClass IIStop using Specialty Process Labs Thyroid USP
Subpotent Drug
- 2026-01-28FDA-DrugGraviti Pharmaceuticals Private LimitedClass IIStop using Rising Pharmaceuticals Furosemide tablets
Presence of Foreign Substance
- 2026-01-28FDA-DrugCipla USA, Inc.Class IIIStop using Cipla Diclofenac Sodium Topical Gel
Failed PH Specifications
- 2026-01-21FDA-DrugCipla USA, Inc.Class IIStop using Cipla Lanreotide Injection
Presence of Particulate Matter.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using recalled Colgate and Crest toothpaste
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IICheck your Axe and Lucky deodorants
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief